Edwards Lifesciences, a leader in advanced cardiovascular disease
treatments, is the number-one heart valve company in the world and the
global leader in acute hemodynamic monitoring.
Headquartered in Irvine, Calif., Edwards focuses on specific
cardiovascular opportunities including heart valve disease, peripheral
vascular disease and critical care technologies.
The company's global
brands, which are sold in approximately 100 countries, include Carpentier-Edwards,
Cosgrove-Edwards, Fogarty, LifeStent, PERIMOUNT and Swan-Ganz.